한빛사
>
한빛사논문
한빛사논문
- 조회189
Exp. Mol. Med., May 01 2024, | https://doi.org/10.1038/s12276-024-01222-1
Glycerol 3-phosphate dehydrogenases (1 and 2) in cancer and other diseases
Sehyun Oh1,2,4, Xuan Linh Mai1,4, Jiwoo Kim1, Arvie Camille V. de Guzman1, Ji Yun Lee1 and Sunghyouk Park1,3
1College of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 08826, Korea.
2Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
3School of Biological Sciences, Seoul National University, Seoul 08826, Korea.
4These authors contributed equally: Sehyun Oh, Xuan Linh Mai.
Corresponding authors : Correspondence to Ji Yun Lee or Sunghyouk Park.
Abstract
The glycerol 3-phosphate shuttle (GPS) is composed of two different enzymes: cytosolic NAD
+-linked glycerol 3-phosphate dehydrogenase 1 (GPD1) and mitochondrial FAD-linked glycerol 3-phosphate dehydrogenase 2 (GPD2). These two enzymes work together to act as an NADH shuttle for mitochondrial bioenergetics and function as an important bridge between glucose and lipid metabolism. Since these genes were discovered in the 1960s, their abnormal expression has been described in various metabolic diseases and tumors. Nevertheless, it took a long time until scientists could investigate the causal relationship of these enzymes in those pathophysiological conditions. To date, numerous studies have explored the involvement and mechanisms of GPD1 and GPD2 in cancer and other diseases, encompassing reports of controversial and non-conventional mechanisms. In this review, we summarize and update current knowledge regarding the functions and effects of GPS to provide an overview of how the enzymes influence disease conditions. The potential and challenges of developing therapeutic strategies targeting these enzymes are also discussed.
논문정보
- Review Paper
- 2024년 05월 (BRIC 등록일 2024-05-02)
- 국내(교신)+국외 연구진
- 생명과학 > 생화학
댓글 작성 로그인
팝업 닫기관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
